Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer
Sunday, October 10, 2010 - 09:20
in Health & Medicine
MILAN, ITALY - October 10, 2010 - Novocure reported today that patients with advanced non-small cell lung cancer (NSCLC) achieved a significant increase in survival time when tumor treating fields...